(S)-4-(4-(tert-Butoxycarbonyl)-1,4-oxazepan-7-yl)benzoic acid

Catalog No.: 
ACDDZN750
CAS No.: 
2382312-99-2
Molecular Formula: 
C17H23NO5
Molecular Weight: 
321.37
(S)-4-(4-(tert-Butoxycarbonyl)-1,4-oxazepan-7-yl)benzoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$3660.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-4-(4-(tert-Butoxycarbonyl)-1,4-oxazepan-7-yl)benzoic acid
IUPAC Name(S)-4-(4-(tert-butoxycarbonyl)-1,4-oxazepan-7-yl)benzoic acid
Molecular FormulaC17H23NO5
Molecular Weight321.37
SMILESO=C(O)C1=CC=C([C@@H]2CCN(C(OC(C)(C)C)=O)CCO2)C=C1
InChI KeyIAEFJTMAVCYOHN-AWEZNQCLSA-N
Synonym(S)-4-(4-(tert-butoxycarbonyl)-1,4-oxazepan-7-yl)benzoic acid;1,4-Oxazepine-4(5H)-carboxylic acid, 7-(4-carboxyphenyl)tetrahydro-, 4-(1,1-dimethylethyl) ester, (7S)-
CAS No.2382312-99-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACDDZN750 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDDZN750 route product structure diagram
    ACDDZN7502382312-99-2
Inquiry

2. ACDDZN750 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDDZN750 route product structure diagram
    ACDDZN7502382312-99-2
Inquiry

3. ACDDZN750 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDDZN750 route product structure diagram
    ACDDZN7502382312-99-2
Inquiry

Comments (0)